HCQ for Non Europeans With Mild to Severe UC
Condition:   Ulcerative Colitis (Disorder) Interventions:   Drug: Hydroxychloroquine;   Drug: Mesalamine Sponsors:   Icahn School of Medicine at Mount Sinai;   Crohn's and Colitis Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2021 Category: Research Source Type: clinical trials

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
Condition:   2019 Novel Coronavirus Interventions:   Drug: HCQ01;   Other: standard of care (SOC) for COVID-19 Sponsors:   Ministry of Health Jordan;   King Hussein Cancer Center;   ACDIMA Biocenter;   Amman Pharmaceutical Industries;   Sana Pharmaceutical Industry Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2021 Category: Research Source Type: clinical trials